Reengineering Intravenous Drug and Fluid Administration Processes in the Operating Room: Step One: Task Analysis of Existing Processes

Background A reengineering approach to intravenous drug and fluid administration processes could improve anesthesia care. In this initial study, current intravenous administration tasks were examined to identify opportunities for improved design. Methods After institutional review board approval was obtained, an observer sat in the operating room and categorized, in real time, anesthesia providers’ activities during 35 cases (∼90 h) into 66 task categories focused on drug/fluid tasks. Both initial room set-up at the beginning of a typical workday and cardiac and noncardiac general anesthesia cases were studied. User errors and inefficiencies were noted. The time required to prepare de novo a syringe containing a mock emergency drug was measured using a standard protocol. Results Drug/fluid tasks consumed almost 50 and 75%, respectively, of the set-up time for noncardiac and cardiac cases. In 8 cardiac anesthetics, drug/fluid tasks comprised 27 ± 6% (mean ± SD) of all prebypass clinical activities. During 20 noncardiac cases, drug/fluid tasks comprised 20 ± 8% of induction and 15 ± 7% of maintenance. Drug preparation far outweighed drug administration tasks. Inefficient or error prone tasks were observed during drug/fluid preparation (e.g., supply acquisition, waste disposal, syringe labeling), administration (infusion device failure, leaking stopcock), and organization (workspace organization and navigation, untangling of intravenous lines). Anesthesia providers (n = 21) required 35 ± 5 s to prepare a mock emergency drug. Conclusions Intravenous drug and fluid administration tasks account for a significant proportion of anesthesia care, especially in complex cases. Current processes are inefficient and may predispose to medical error. There appears to be substantial opportunity to improve quality and cost of care through the reengineering of anesthesia intravenous drug and fluid administration processes. General design requirements are proposed.

[1]  R. Gillerman,et al.  Drug Use Inefficiency: A Hidden Source of Wasted Health Care Dollars , 2000, Anesthesia and analgesia.

[2]  D M Gaba,et al.  Case 2-1992. Unintentional delivery of vasoactive drugs with an electromechanical infusion device. , 1992, Journal of cardiothoracic and vascular anesthesia.

[3]  David A. Lubarsky,et al.  Using an anesthesia information management system as a cost containment tool. Description and validation. , 1997 .

[4]  T. Brennan,et al.  INCIDENCE OF ADVERSE EVENTS AND NEGLIGENCE IN HOSPITALIZED PATIENTS , 2008 .

[5]  M. Weinger,et al.  Drug wastage contributes significantly to the cost of routine anesthesia care. , 2001, Journal of clinical anesthesia.

[6]  D M Gaba,et al.  The Effect of Electronic Record Keeping and Transesophageal Echocardiography on Task Distribution, Workload, and Vigilance During Cardiac Anesthesia , 1997, Anesthesiology.

[7]  T. Brennan,et al.  Incidence and types of adverse events and negligent care in Utah and Colorado. , 2000, Medical care.

[8]  W. J. Russell,et al.  Errors, Incidents and Accidents in Anaesthetic Practice , 1993 .

[9]  Matthew B Weinger,et al.  Assessment of the Intrarater and Interrater Reliability of an Established Clinical Task Analysis Methodology , 2002, Anesthesiology.

[10]  N. Dickey,et al.  Systems analysis of adverse drug events. , 1996, JAMA.

[11]  Matthew B. Weinger,et al.  An Objective Methodology for Task Analysis and Workload Assessment in Anesthesia Providers , 1994, Anesthesiology.

[12]  R S Newbower,et al.  An Analysis of Major Errors and Equipment Failures in Anesthesia Management: Considerations for Prevention and Detection , 1984, Anesthesiology.

[13]  Matthew B. Weinger,et al.  Ergonomic and Human Factors Affecting Anesthetic Vigilance and Monitoring Performance in the Operating Room Environment , 1990, Anesthesiology.

[14]  D. Bates,et al.  Systems analysis of adverse drug events. ADE Prevention Study Group. , 1995, JAMA.

[15]  E. Jochimsen,et al.  Staphylococcus Aureus Bloodstream Infections Among Patients Undergoing Electroconvulsive Therapy Traced to Breaks in Infection Control and Possible Extrinsic Contamination by Propofol , 1997, Anesthesia and analgesia.

[16]  R S Newbower,et al.  Preventable anesthesia mishaps: a study of human factors* , 1978, Anesthesiology.

[17]  F. Dexter,et al.  A Method to Compare Costs of Drugs and Supplies among Anesthesia Providers: A Simple Statistical Method to Reduce Variations in Cost Due to Variations in Casemix , 1998, Anesthesiology.

[18]  M. Wiklund,et al.  Incorporating human factors into the design of medical devices. , 1998, JAMA.

[19]  Matthew B. Weinger,et al.  A331 Naloxonazine blocks alfentanil-induced analgesia but not muscle rigidity in the rat , 1990 .

[20]  Lon Roberts,et al.  Process Reengineering: The Key to Achieving Breakthrough Success , 1994 .

[21]  Enid Mumford,et al.  Reengineering the Corporation: A Manifesto for Business Revolution , 1995 .